
PM of $PINK Shares for the Cure. Healthcare Hedgefund Manager for past 20 yrs. Scientist, Virologist, Humanitarian, Troglodyte w/a keyboard.
New York, NY
Joined May 2009
- Tweets24.8K
- Following602
- Followers63.4K
- Likes3.4K
I have felt this in:
2001 Internet bubble
2007 Housing bubble
2012 EU debt bubble
2020 Covid crisis
2026 AI bubble
The same situation where the math does not work.
It is RARE and it is NOW.
We are now seeing demand destruction due to price.
2027 IMHO will be BLOTTO
@Seawolfcap @Hedgeye @KeithMcCullough @profplum99
$INTC and soon lots of other things: The cure to high prices is often high prices.
@profplum99
The $INTC (down 17% in after hours) guide down should not be extrapolated on $NVDA (down 1.3%).
Bottom line: Main issue is PC demand. If there is pricing pressure on DCAI it suggests they are likely losing share.
The company is calling like it is, demand is slowing because of high memory costs.
That’s a read on how customers fell about their chips. If customers were demanding them, high memory costs would have little impact on demand.
Nvidia has been beating numbers despite high memory costs and Jensen was bullish last week at GTC Berlin. $SPCX, $META, $GOOG all said Capex in CY27 will be signfnalty higher than 2026. The Street is looking for 42% growth compared to $82% this year.
Michael Taylor retweeted
Replying to @Mike_Taylor1972
After the Oct tech hit looks like Mike may be right again. His 2026 predictions have a strong batting avg. Things may get interesting post election.
Going on at 2PM - be there!
A follow up to "the" AI Bubble and more
AI can change the world—and still lose you money.
LIVE today, 2 PM ET: @Mike_Taylor1972 & @SPGlobal’s Melissa Otto on AI profits, prices and portfolio risk. @DukeU’s @camharvey also hoping to join.
At 3 PM: Bill Janeway on what past tech booms teach us.
Join @inspiredmoneyfm:
youtube.com/live/t4HdeLikUYU
Michael Taylor retweeted
THE $TE TURNAROUND COULD BE STARTING RIGHT NOW
T1 could be approaching one of most interesting turnaround opportunities in the energy sector right now because while the market continues valuing T1 Energy like a struggling solar manufacturer with significant financing risks when I think we're finally beginning to see the pieces come together for a potentially dramatic improvement in its underlying economics starting in 2027.
What makes this particularly interesting is that T1 isn't some speculative company hoping to eventually build a solar manufacturing business because it already operates G1_Dallas which produced 935 MW of solar modules during Q2 and generated approximately $250M in quarterly revenue, representing nearly 90% growth year over year.
However biggest limitation of current business model is that T1 still purchases solar cells from third parties before assembling them into finished modules which means a meaningful portion of the economics are captured elsewhere in the supply chain which is why I think the upcoming G2_Austin facility could fundamentally change investment thesis because instead of simply assembling modules using purchased components, T1 is moving toward controlling the manufacturing process from domestically sourced polysilicon and wafers through finished solar cells and modules.
I think that's an important distinction because the real opportunity isn't necessarily selling significantly more solar panels at today's margins but capturing substantially more profit on every module sold as the company brings one of most valuable parts of the supply chain in-house with the stock trading near multiyear lows and investors increasingly concerned about the company's ability to finance that transition I think we're approaching the point where successful execution could begin creating a meaningful disconnect between what the market is pricing in today and what the business could eventually become.
The biggest reason I'm becoming increasingly constructive on T1 is that G2_Austin is finally moving from an ambitious manufacturing plan toward a tangible production milestone with management targeting initial operations during the first quarter of 2027.
The first phase is expected to provide approximately 2.1 GW of annual solar cell manufacturing capacity which would complement the existing 5 GW module capacity at G1_Dallas and allow T1 to capture economics that currently flow to external suppliers.
Meanwhile T1 has already secured approximately 3 GW in firm customer commitments, including a 641 MW agreement with Clearway and another 900 MW agreement with Treaty Oak, suggesting the company isn't simply investing hundreds of millions of dollars into capacity without identifying customers.
Another development I find particularly interesting is T1's acquisition of the TOPCon intellectual property it previously licensed from Evervolt for approximately $135M, which could eliminate an estimated $25M to $40M in annual licensing expenses while giving the company greater control over its manufacturing technology.
When you combine higher domestic content, better margins from internal cell production and lower licensing expenses, I think there's a credible path toward T1 becoming a materially more profitable business than its recent financial results would suggest but what makes the timing particularly interesting is that several external developments are beginning to work in T1's favor just as its domestic manufacturing capacity approaches production.
What I find even more important is that T1 recently secured a Commerce Department waiver allowing it to import up to 1.725 GW of solar cells while G2_Austin remains under construction, effectively helping bridge the transition without unnecessarily disrupting production at its existing Dallas facility.
That's an important near-term risk reduction because the last thing shareholders need is the company losing revenue or customer relationships while waiting for its own cell manufacturing capacity to come online.
There's also another potentially overlooked opportunity in Norway, where local officials approved the conversion of part of T1's Giga Arctic campus into a data center facility, with 50 MW of allocated grid capacity and a position in the queue for additional power that could eventually bring total access to 396 MW.
I wouldn't assign significant value to that opportunity until management secures an actual commercialization or monetization agreement, but I think it introduces another potential source of capital at a time when financing its U.S. manufacturing expansion remains the company's biggest challenge.
Between the improving policy environment, temporary import flexibility, contracted customer demand and potential monetization of noncore assets, I think several important pieces of the turnaround are beginning to align.
Management has already raised $120M through convertible debt, but additional financing remains necessary, and I think that's the single biggest factor investors need to monitor because raising capital through additional debt or equity could materially affect how much of the eventual turnaround accrues to existing shareholders.
That's why November 12 becomes such an important checkpoint, as I'll be watching for further progress on G2 construction, stronger underlying operating margins, a credible financing solution and confirmation that initial cell production remains on schedule for Q1 2027.
However, what makes the opportunity compelling to me is that the market appears to be pricing in substantial execution and financing uncertainty at precisely the moment when several catalysts could begin reducing that uncertainty.
I don't think the turnaround has been proven yet, but I think the foundations are becoming increasingly visible, and if management successfully finances G2, brings domestic cell production online and begins demonstrating the margin improvement it has outlined, there's a credible argument that today's valuation could eventually look extraordinarily cheap.
That's why I think the next several months could mark the beginning of a much more meaningful turnaround for T1 rather than simply another temporary rally in a beaten-down solar stock.
This is what it took to safely get the opposition candidate out.
Remarkable.
Secretary of State Marco Rubio has secured the safe transfer of Flavio Bolsonaro to the United States of America.
Long live Brazil. Flavio can now fight this battle from abroad in the safe hands of the USA.
This is why we need Republicans in power. Democrats would have never allowed Flavio to be safely transferred to the USA.
Nerd-out on AI
If ETH = False
(And yes they are likely talking their book)
It is just a matter of time before crypto gets busted.
…also a matter of time before we have major advances everywhere.
youtu.be/lskEzJ7ixw0?is=sii6…
France #MSM Narrative:
"the Far Right is the greatest danger to us all"
...
reuters.com/world/europe/fra…
$NVDA - as I put the pieces together on how the AI bubble pops, I realize NVDA could take a last gasp effort to rope Insurance cos into the datactr trade w first-loss debt.
-keep an eye out for that.
This is exactly the problem IMHO w the $MRNA study and result.
- payers will have great difficulty with this one.
Agree — and to be clear, this is not a comment on whether $MRNA Phase 3 itself succeeded. From a commercialization and ultimate patient-benefit standpoint, the logic is straightforward: if simply moving a few doses of pembrolizumab earlier (before surgery) can already deliver a large relative risk reduction, why add a fully personalized vaccine on top later?
INTerpath-001 showed an RFS HR of 0.58 (2-year RFS 82.2% vs 70.0%) and DMFS HR of 0.62 for intismeran + pembro versus adjuvant pembro alone — nearly identical to the HR 0.58 from neoadjuvant pembro versus adjuvant pembro in SWOG S1801.
That overlap is hard to dismiss when the vaccine requires individualized manufacturing and logistics at very high cost. Cost-effectiveness looks challenging when a simpler neoadjuvant approach can produce a similar relative benefit. This is also a key reason $BNTX has leaned toward off-the-shelf mRNA strategies rather than fully personalized ones.
I’ve been saying the market’s expectations after the August topline were too aggressive. These numbers look like a solid but incremental adjuvant result, not the major paradigm shift that was priced in.
Michael Taylor retweeted
The problem with data ctr collateral, rev recognition, neg pricing and $NVDA:
Debt is “Secured”:
Much neocloud debt is secured with a guarantee net-net by $NVDA. The collateral is the GPUs themselves.
Rev Recognition “oops I did it again”:
Imagine $NVDA projects 100 units sold (at 100% growth) for 2027. BUT what if for one reason or another, only 60 get placed into slowly-assembled data ctrs? Production, pricing and scarcity of supply abruptly ends if the parabolic build of data centers slow.
Negative Pricing begins for GPUs, memory …and importantly, the collateral.
The Collateral of that data ctr loan is a GPU that now has LOWER value as supply constraint abates.
In fact, that collateral is terrible, as if one calls in on any, they ALL tank in value, accelerating the daisy chain.
What worries me greatly, is as I have pointed this out to my peers, very few have thought this through. “Yeah but it’s $NVDA, a $5trn company”.
My only answer: “NOT if datactr growth is slowing, bc they will immediately lose pricing power, margins, and are on the hook for SOOOO much collateral, it’s mind bending”
Side note: There is NO government rescue for this one.
Now- get in there and tell me how I am an idiot.
Beware, there is a queue!
Friday at @IMS was a very big day.
5x World champ, Alex Palou v @maxtaylorracing in a dogfight
- LETS GO MAX -
instagram.com/reel/Deu2nvMhH…
$TE Many may not realize the significance of this PR - IMHO the commerce dept affirms that $TE is a “US co” now and opens the door for FINANCING of G2 and beyond.
This may have been a rate-limiting step to a long awaited funding solve.
ir.t1energy.com/news-release…
My friends Anthropic/OAI have about >$800bn in commitments to keep the AI “fire” going, contingent on IPOs /debt offering - what looks to be in double digits % yield
Recall, the 2008 US housing bailout was of a similar size
This is a debt/raise number similar to 2% of US GDP
2026 predictions - got a lot right, a bit wrong (i thought interest rates would be the reverse of this).
Walz, Newsome and Omar …kinda got right.
Not a doomer. But the excess supply is real.
Business Insider confirms it: Amazon has warehouses of GPUs that can’t be installed, and is buying them so far in advance that a supply chain team said they “didn’t have a clear forecasted path” to installing them.
businessinsider.com/amazon-2…
I sense $NVDA may take extreme measures, as if guaranteeing returns to their client debt investors is not extreme enough.
Extreme-er on the Horizon!!
(IMHO We have an inventory problem, soon to be a rev rec problem).
A must-watch.
We Followed The World's Deadliest Migration Route Into Europe - FULL DOC... youtu.be/svJUbYFCRPc?is=mQt6… via @YouTube











